Study: Diabetes and Weight-Loss Drugs Halve Risk of Alcohol-Use Disorder

24 August 2024

A recent study conducted by researchers at Case Western Reserve University School of Medicine suggests that semaglutide, a medication commonly used in widespread diabetes and…

Continue reading →

Rising Use of Ozempic and Wegovy Among Privately Insured Patients Could Exacerbate Health Disparities

14 August 2024

A recent study from the University of Southern California reveals that publicly insured individuals who are most likely to benefit from new medications for diabetes…

Continue reading →

Common weight loss medications associated with rare vision impairment condition

14 August 2024

A recent study spearheaded by researchers from Mass Eye and Ear indicates a higher incidence of a potentially blinding eye condition called NAION among patients…

Continue reading →

More young individuals are turning to Wegovy and Ozempic

13 August 2024

Public interest in weight management medications such as Wegovy and Ozempic is experiencing a remarkable surge. Yet, comprehensive national data on their distribution across the…

Continue reading →